Authors:
GUSTAVSSON P
GARELLI E
DRAPTCHINSKAIA N
BALL S
WILLIG TN
TENTLER D
DIANZANI I
PUNNETT HH
SHAFER FE
CARIO H
RAMENGHI U
GLOMSTEIN A
PFEIFFER RA
GORINGE A
OLIVIERI NF
SMIBERT E
TCHERNIA G
ELINDER G
DAHL N
Citation: P. Gustavsson et al., IDENTIFICATION OF MICRODELETIONS SPANNING THE DIAMOND-BLACKFAN ANEMIALOCUS ON 19Q13 AND EVIDENCE FOR GENETIC-HETEROGENEITY, American journal of human genetics, 63(5), 1998, pp. 1388-1395
Authors:
SCHMIEGELOW K
GLOMSTEIN A
KRISTINSSON J
SALMI T
SCHRODER H
BJORK O
Citation: K. Schmiegelow et al., IMPACT OF MORNING VERSUS EVENING SCHEDULE FOR ORAL METHOTREXATE AND 6-MERCAPTOPURINE ON RELAPSE RISK FOR CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Journal of pediatric hematology/oncology, 19(2), 1997, pp. 102-109
Authors:
MOE PJ
HOLEN A
GLOMSTEIN A
MADSEN B
HELLEBOSTAD M
STOKLAND T
WEFRING KW
STEENJOHNSEN J
NIELSEN B
HOWLID H
BORSTING S
HAPNES C
Citation: Pj. Moe et al., LONG-TERM SURVIVAL AND QUALITY-OF-LIFE IN PATIENTS TREATED WITH A NATIONAL ALL PROTOCOL 15-20 YEARS EARLIER - IDM HDM AND LATE EFFECTS/, Pediatric hematology and oncology, 14(6), 1997, pp. 513-524
Authors:
SAARINEN UM
MELLANDER L
NYSOM K
RINGDEN O
SCHROEDER H
GLOMSTEIN A
GUSTAFSSON G
Citation: Um. Saarinen et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION IN FIRST REMISSION FOR CHILDREN WITH VERY HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA - A RETROSPECTIVE CASE-CONTROL STUDY IN THE NORDIC COUNTRIES, Bone marrow transplantation, 17(3), 1996, pp. 357-363
Citation: Sa. Evensen et al., HEPATITIS-C VIRUS SEROCONVERSION IN A HEMOPHILIAC TREATED EXCLUSIVELYWITH SOLVENT DETERGENT-TREATED CLOTTING FACTOR CONCENTRATE, European journal of clinical microbiology & infectious diseases, 14(7), 1995, pp. 631-632
Authors:
SCHMIEGELOW K
SCHRODER H
GUSTAFSSON G
KRISTINSSON J
GLOMSTEIN A
SALMI T
WRANNE L
Citation: K. Schmiegelow et al., RISK OF RELAPSE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA IS RELATED TO RBC METHOTREXATE AND MERCAPTOPURINE METABOLITES DURING MAINTENANCE CHEMOTHERAPY, Journal of clinical oncology, 13(2), 1995, pp. 345-351